These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16875897)

  • 21. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction.
    Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C
    J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention.
    Brophy JM; Babapulle MN; Costa V; Rinfret S
    Am Heart J; 2006 Aug; 152(2):263-9. PubMed ID: 16875906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial.
    Suh JW; Cha MJ; Lee SP; Chae IH; Bae JH; Kwon TG; Bae JW; Cho MC; Rha SW; Kim HS
    J Atheroscler Thromb; 2014; 21(2):140-50. PubMed ID: 24140730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Existence of a clinically relevant interaction between clopidogrel and HMG-CoA reductase inhibitors? Re-evaluating the evidence.
    Poulsen TS; Vinholt P; Mickley H; Korsholm L; Kristensen SR; Damkier P
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):103-10. PubMed ID: 15679472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
    Smith SM; Judge HM; Peters G; Storey RF
    Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study.
    Neubauer H; Günesdogan B; Hanefeld C; Spiecker M; Mügge A
    Eur Heart J; 2003 Oct; 24(19):1744-9. PubMed ID: 14522569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do statins really interfere with clopidogrel-induced platelet function?
    Shechter M
    Eur Heart J; 2004 Mar; 25(5):448; author reply 448-9. PubMed ID: 15033262
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.
    Zahno A; Brecht K; Bodmer M; Bur D; Tsakiris DA; Krähenbühl S
    Br J Pharmacol; 2010 Sep; 161(2):393-404. PubMed ID: 20735423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Statin and clopidogrel pharmacological interaction].
    Leoncini M; Toso A; Maioli M; Bellandi F
    G Ital Cardiol (Rome); 2013 Sep; 14(9):574-84. PubMed ID: 23903277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4.
    Polena S; Gupta MP; Shaikh H; Zazzali K; Coplan N; Gintautas J; Labana SS; Soffer D
    Proc West Pharmacol Soc; 2008; 51():60-2. PubMed ID: 19544679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis.
    Lotfi A; Schweiger MJ; Giugliano GR; Murphy SA; Cannon CP;
    Am Heart J; 2008 May; 155(5):954-8. PubMed ID: 18440347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanisms of drug-induced aspirin and clopidogrel resistance.
    Schroeder WS; Ghobrial L; Gandhi PJ
    J Thromb Thrombolysis; 2006 Oct; 22(2):139-50. PubMed ID: 17008981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clopidogrel "resistance" and statin cotreatment - significant for cardiocoronary prevention in real life?
    Schrör K; Weber AA; Hohlfeld T
    Thromb Haemost; 2005 Aug; 94(2):235-7. PubMed ID: 16113810
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin.
    Rao N
    J Clin Pharmacol; 2011 May; 51(5):784. PubMed ID: 20671297
    [No Abstract]   [Full Text] [Related]  

  • 38. Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition.
    Luzak B; Rywaniak J; Stanczyk L; Watala C
    Eur J Clin Invest; 2012 Aug; 42(8):864-72. PubMed ID: 22409214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interactions of statins with antithrombotic drugs].
    Ruef J
    Med Klin (Munich); 2004 Feb; 99(2):65-70. PubMed ID: 14963656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Individual pharmacotherapy safety in the assessment of cytochrome P-450 3A4 (CYP3A4) isoenzyme activity].
    Sivkov AS; Paukov SV; Ruvinov IuV; Kukes IV
    Klin Med (Mosk); 2010; 88(2):61-7. PubMed ID: 21105476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.